News

Global award honors entrepreneurship, innovation, and personal commitment

Supporting rare disease diagnosis, education, and clinical research

Driving Accelerated Diagnosis and Treatment Development

Driving personalized, immune-based therapy to target patients’ own immune responses

CENTOGENE biomarker measures lyso-Gb1 levels in children

Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database

Artificial Intelligence verbessert die Diagnose seltener Erkrankungen, basierend auf der weltweit größten kuratierten Mutationsdatenbank

Research findings may provide deeper understanding on the role of genes that can contribute to development of Hypophosphatasia.

In a whitepaper released today, CENTOGENE provided an update on its induced pluripotent stem cells (iPSC) program.

CENTOGENE today welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of…